15,803 Shares in DocuSign, Inc. (NASDAQ:DOCU) Acquired by Quantbot Technologies LP

Quantbot Technologies LP bought a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) during the 4th quarter, Holdings Channel reports. The firm bought 15,803 shares of the company’s stock, valued at approximately $1,421,000.

Other institutional investors also recently added to or reduced their stakes in the company. Amundi raised its stake in shares of DocuSign by 565.8% during the fourth quarter. Amundi now owns 1,379,575 shares of the company’s stock valued at $123,486,000 after purchasing an additional 1,172,368 shares in the last quarter. Bank of New York Mellon Corp increased its stake in DocuSign by 61.5% during the 4th quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company’s stock valued at $150,525,000 after buying an additional 637,505 shares during the period. Fiera Capital Corp bought a new stake in shares of DocuSign during the 4th quarter worth about $47,920,000. Principal Financial Group Inc. lifted its stake in shares of DocuSign by 3,026.7% in the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock worth $49,179,000 after acquiring an additional 529,308 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of DocuSign by 42.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock valued at $90,625,000 after acquiring an additional 434,312 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Stock Up 1.1 %

Shares of DocuSign stock opened at $89.00 on Tuesday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The stock has a market capitalization of $18.02 billion, a P/E ratio of 18.35, a PEG ratio of 6.94 and a beta of 1.02. The stock has a 50 day moving average price of $87.52 and a two-hundred day moving average price of $80.69.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.76 earnings per share. Sell-side analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on DOCU shares. Jefferies Financial Group boosted their target price on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Piper Sandler upped their price objective on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 target price on shares of DocuSign in a report on Friday, March 14th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research report on Friday, March 14th. Finally, Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $95.00.

Insider Activity

In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total value of $3,601,600.00. Following the sale, the chief executive officer now directly owns 156,050 shares in the company, valued at $14,050,742. This represents a 20.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now owns 8,270 shares of the company’s stock, valued at $722,880.70. This trade represents a 6.07 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 97,851 shares of company stock worth $8,579,369. Company insiders own 1.66% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.